215 related articles for article (PubMed ID: 9485091)
1. Circulating Vdelta1+ T cells are activated and accumulate in the skin of systemic sclerosis patients.
Giacomelli R; Matucci-Cerinic M; Cipriani P; Ghersetich I; Lattanzio R; Pavan A; Pignone A; Cagnoni ML; Lotti T; Tonietti G
Arthritis Rheum; 1998 Feb; 41(2):327-34. PubMed ID: 9485091
[TBL] [Abstract][Full Text] [Related]
2. Resistance to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis.
Cipriani P; Fulminis A; Pingiotti E; Marrelli A; Liakouli V; Perricone R; Pignone A; Matucci-Cerinic M; Giacomelli R
J Rheumatol; 2006 Oct; 33(10):2003-14. PubMed ID: 17014016
[TBL] [Abstract][Full Text] [Related]
3. Endothelial/lymphocyte activation leads to prominent CD4+ T cell infiltration in the gastric mucosa of patients with systemic sclerosis.
Manetti M; Neumann E; Müller A; Schmeiser T; Saar P; Milia AF; Endlicher E; Roeb E; Messerini L; Matucci-Cerinic M; Ibba-Manneschi L; Müller-Ladner U
Arthritis Rheum; 2008 Sep; 58(9):2866-73. PubMed ID: 18759276
[TBL] [Abstract][Full Text] [Related]
4. Reduced circulating natural killer T cells and gamma/delta T cells in patients with systemic sclerosis.
Riccieri V; Parisi G; Spadaro A; Scrivo R; Barone F; Moretti T; Bernardini G; Strom R; Taccari E; Valesini G
J Rheumatol; 2005 Feb; 32(2):283-6. PubMed ID: 15693088
[TBL] [Abstract][Full Text] [Related]
5. Increased transendothelial migration of scleroderma lymphocytes.
Stummvoll GH; Aringer M; Grisar J; Steiner CW; Smolen JS; Knobler R; Graninger WB
Ann Rheum Dis; 2004 May; 63(5):569-74. PubMed ID: 15082489
[TBL] [Abstract][Full Text] [Related]
6. Circulating γ/δ T cells in systemic sclerosis exhibit activated phenotype and enhance gene expression of proalpha2(I) collagen of fibroblasts.
Ueda-Hayakawa I; Hasegawa M; Hamaguchi Y; Takehara K; Fujimoto M
J Dermatol Sci; 2013 Jan; 69(1):54-60. PubMed ID: 23159281
[TBL] [Abstract][Full Text] [Related]
7. Expansion of selected V delta 1+ gamma delta T cells in systemic sclerosis patients.
Yurovsky VV; Sutton PA; Schulze DH; Wigley FM; Wise RA; Howard RF; White B
J Immunol; 1994 Jul; 153(2):881-91. PubMed ID: 8021519
[TBL] [Abstract][Full Text] [Related]
8. Increased peripheral blood gamma delta+ T cells and natural killer cells in Behçet's disease.
Suzuki Y; Hoshi K; Matsuda T; Mizushima Y
J Rheumatol; 1992 Apr; 19(4):588-92. PubMed ID: 1534375
[TBL] [Abstract][Full Text] [Related]
9. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.
York MR; Nagai T; Mangini AJ; Lemaire R; van Seventer JM; Lafyatis R
Arthritis Rheum; 2007 Mar; 56(3):1010-20. PubMed ID: 17328080
[TBL] [Abstract][Full Text] [Related]
10. Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid.
Poggi A; Venturino C; Catellani S; Clavio M; Miglino M; Gobbi M; Steinle A; Ghia P; Stella S; Caligaris-Cappio F; Zocchi MR
Cancer Res; 2004 Dec; 64(24):9172-9. PubMed ID: 15604289
[TBL] [Abstract][Full Text] [Related]
11. Gamma delta T cell receptor subsets in the lung of patients with HIV-1 infection.
Agostini C; Zambello R; Trentin L; Cerutti A; Bulian P; Crivellaro C; Cipriani A; Semenzato G
Cell Immunol; 1994 Jan; 153(1):194-205. PubMed ID: 8287489
[TBL] [Abstract][Full Text] [Related]
12. Role of cellular immunity in systemic sclerosis pathogenesis: update on CD4+T cells population studies.
Beşliu AN; Bănică LM; Lonescu R; Predeţeanu D; Stăvaru C; Marica CM; Chiţonu C; Pistol G; Stefănescu M; Matache C
Roum Arch Microbiol Immunol; 2009; 68(1):5-13. PubMed ID: 19507621
[TBL] [Abstract][Full Text] [Related]
13. [Use of flow cytometry in evaluation of cellular changes in interstitial lung diseases].
Kopiński P
Folia Med Cracov; 1997; 38(3-4):69-115. PubMed ID: 10481384
[TBL] [Abstract][Full Text] [Related]
14. Increased circulating levels of tissue kallikrein in systemic sclerosis correlate with microvascular involvement.
Del Rosso A; Distler O; Milia AF; Emanueli C; Ibba-Manneschi L; Guiducci S; Conforti ML; Generini S; Pignone A; Gay S; Madeddu P; Matucci-Cerinic M
Ann Rheum Dis; 2005 Mar; 64(3):382-7. PubMed ID: 15708892
[TBL] [Abstract][Full Text] [Related]
15. Blood mononuclear cells in patients with HTLV-I-associated myelopathy: lymphocytes are highly activated and adhesion to endothelial cells is increased.
Al-Fahim A; Cabre P; Kastrukoff L; Dorovini-Zis K; Oger J
Cell Immunol; 1999 Nov; 198(1):1-10. PubMed ID: 10612646
[TBL] [Abstract][Full Text] [Related]
16. NKG2C is a major triggering receptor involved in the V[delta]1 T cell-mediated cytotoxicity against HIV-infected CD4 T cells.
Fausther-Bovendo H; Wauquier N; Cherfils-Vicini J; Cremer I; Debré P; Vieillard V
AIDS; 2008 Jan; 22(2):217-26. PubMed ID: 18097224
[TBL] [Abstract][Full Text] [Related]
17. The expression of human leukocyte antigen-DR and CD25 on circulating T cells in cutaneous lupus erythematosus and correlation with disease activity.
Wenzel J; Henze S; Brähler S; Bieber T; Tüting T
Exp Dermatol; 2005 Jun; 14(6):454-9. PubMed ID: 15885081
[TBL] [Abstract][Full Text] [Related]
18. Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis.
Fuschiotti P; Medsger TA; Morel PA
Arthritis Rheum; 2009 Apr; 60(4):1119-28. PubMed ID: 19333920
[TBL] [Abstract][Full Text] [Related]
19. Evidence for B cell-mediated activation of V delta 1+ T lymphocytes during progression of HIV infection.
Hyjek EM; Bartkowiak J; Drozdz R; Wasik TJ; Jasinski M; Kaneko Y; Lischner HW; Kozbor D
J Immunol; 1997 Jan; 158(1):464-74. PubMed ID: 8977224
[TBL] [Abstract][Full Text] [Related]
20. Alpha4beta1 and alpha4beta7 CD4 T cell numbers increase and CLA CD4 T cell numbers decrease in systemic sclerosis.
Scala E; Paganelli R; Sampogna F; Abeni D; Colonna L; De Pità O; Puddu P; Russo G
Clin Exp Immunol; 2005 Mar; 139(3):551-7. PubMed ID: 15730402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
